期刊文献+

肺癌患者并发医院获得性肺炎的临床分析

Clinical Analysis of Patients with Lung cancer Complicated with Pneumonia
下载PDF
导出
摘要 【目的】探讨肺癌患者医院获得性肺炎(HAP)的临床特点。【方法】对本院收治的198名肺癌患者并发HAP70例的治疗因素、临床分期、年龄及白细胞计数、病原菌、药敏试验结果及抗生素应用情况进行回顾性分析。【结果】高龄、临床分期晚、化疗、白细胞降低是肺癌并发HAP的危险因素。【结论】肺癌患者并发HAP的危险因素多,应加强预防,重视细菌培养和药敏试验,合理使用抗生素。 [Objective]To explore the clinical features of patients with lung cancer complicated with hospital acquired pneumonia. [Methods] Seventy cases of hospital acquired pneumonia in 198 cases with lung cancer were investigated retrospectively. The treatment factors, clinical stages, age, leucocyte count, pathogenic bacteria, drug sensitivity test and antibiotic usage during 2007-2008 were analyzed. [Results] Advanced age, chemotherapy and decreased white cell were dangerous factors of lung cancer complicated with hospital acquired pneumonia. [Conclusion] There are many factors of hospital acquired pneumonia in the patients with lung cancer. To improve the patients' life quality, the prevention should be strengthened, and drug sensitivity test and the culture of bacteria should be emphasized, and antibiotics should be used rationally.
机构地区 湖南省肿瘤医院
出处 《医学临床研究》 CAS 2009年第5期824-826,共3页 Journal of Clinical Research
关键词 肺肿瘤/并发症 肺炎/并发症 交叉感染 lung neoplasms/CO pneumonia/CO cross infection
  • 相关文献

参考文献8

二级参考文献34

  • 1沈定霞,罗燕萍,崔岩,赵莉萍,白立彦.分离产金属β-内酰胺酶的铜绿假单胞菌[J].中华医院感染学杂志,2004,14(1):86-88. 被引量:109
  • 2蔡少华,张进川,俞森洋,刘长庭,钱桂生.呼吸机相关肺炎的病原学和耐药性监测[J].中华医院感染学杂志,2004,14(4):365-368. 被引量:98
  • 3周正任 李长荣 等.肿瘤病人外周血T细胞及亚群和NK细胞活性变化的研究[J].中国免疫学杂志,1987,3(5):285-285.
  • 4郭汝涛 高永君 等.非小细胞肺癌的非手术治疗评价[J].中华放射肿瘤学杂志,1999,3:130-130.
  • 5Coudron PE, Moland ES, Thomoson KS. Occurrence and detection of AmpC β-lactamase Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis isolates at a veteranis medical center. J Clin Microbiol, 2000,38: 1791-1796.
  • 6Philippon A, Arlet G, Jacoby GA. Plasmid-determined AmpC-type β-lactamase. Antimicrob Agents Chemother, 2002, 46: 1-11.
  • 7Yan J J, Ko WC, Jung YC, et al. Emergence of Klebsiella pneumoniae isolates producing inducible DHA-1 beta-lactamases in a university hospital in Taiwan. J Clin Microbiol, 2002, 40: 3121-3126.
  • 8Bradford PA, Urban C, Mariano N, et al. Imipenem resistance in Klebsiella pneumoniae is associated with combination of ACT-1, a plasmid-mediated AmpC bete-lactamase, and the loss of an outer membrane protein.Antimicrob Agents Chemother, 1997, 41: 563-569.
  • 9Chanawong A, M'Zali FH, Heritage J, et al. Three cefotaximases, CTXM-9, CTX-M-13 and CTX-M -14, among Enterobacteriaceae in the People's Republic of China. Antimicrob Agents Chemother, 2002, 46: 630-637.
  • 10Yan JJ, Ko WC, Tsai SH, et al. Desseminatinn of CTX-M-3 and CMY-2 β-lactamase among clinical isolates of Escherichia coli in southerm Taiwan. J Clin Microbiol, 2000, 38: 4320-4325.

共引文献154

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部